510(k) Report

510(k) · Cleared

Cleared

ClearHemograsper

K242857510(k) TraditionalCleared May 21, 2025243-day reviewClass II21 CFR 876.4300

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Finemedix Co., Ltd. · KGE Forceps, Biopsy, Electric

Cleared on May 21, 2025 as substantially equivalent to K062517 (Olympus Medical Systems Corporation, 2006) after a 243-day review. Its family tree reaches back 2 generations to 1996.

Decided
May 21, 2025
Review
243 days
Class
Class II
Product code
KGE
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K955052 (1996). 3 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 1997: 1 other ancestorK955052 · Olympus FD-1/2-1 Hot Biopsy Forceps · Olympus America, Inc. · 1996K062517 · Electrosurgical Hemostatic Forceps Series · Olympus Medical Systems Corporation · 20061995200020052010201520202025
  1. Root · 2 generations backK955052 Olympus FD-1/2-1 Hot Biopsy ForcepsOlympus America, Inc. · 1996
  2. 1 generation backK062517 Electrosurgical Hemostatic Forceps SeriesOlympus Medical Systems Corporation · 2006
  3. This deviceK242857 ClearHemograsperFinemedix Co., Ltd. · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K955052Olympus FD-1/2-1 Hot Biopsy ForcepsOlympus America, Inc.1996—
−1K062517Electrosurgical Hemostatic Forceps SeriesOlympus Medical Systems Corporation2006—
0 (this device)K242857ClearHemograsperFinemedix Co., Ltd.2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
FIG. 1 — Lineage of K242857, 1996–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KGE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KGE device

  1. #1 K251807 Single Use Electrosurgical Hemostatic Forceps…score 11.6 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K062517Electrosurgical Hemostatic Forceps Series
Summary page 5
…dicate Device #1 Manufacturer OLYMPUS MEDICAL SYSTEMS CORP. Trade Name Electrosurgical Hemostatic Forceps Series 510(k) number K062517 5. Description ClearHemograsper is a monopolar endoscopic instrument intended to coagulate or to perform hemostasis using h…
Olympus Medical Systems Corporation2006—

Also cleared against K062517: 5 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 29 years and passes through 3 companies; a new generation was cleared every 18.4 years on median.
  • None of the 3 ancestors has a recall.
  • 5 other devices also cite its predicate K062517.

How does its category compare?

All KGE devices

KGE Forceps, Biopsy, Electric: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · KGE

2in 2025

2009: 22010: 12013: 12014: 12016: 32017: 22018: 32019: 12021: 22022: 12023: 12025: 22026 (partial year): 1
2007high 3 (2016) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KGE

184in 2018

2016: 102 days median2018: 184 days median
2007high 184 (2018) · low 102 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KGE

No recall names KGE since 2007.

Adverse event reports per year · KGE

10in 2025

2007: 42008: 152009: 752010: 292011: 512012: 302013: 142014: 122015: 152016: 92017: 262018: 262019: 152020: 72021: 242022: 162023: 82024: 92025: 10
2007high 75 (2009) · low 4 (2007)2025

MAUDE reports naming product code KGE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—04
20080—015
20092—075
20101—029
20110—051
20120—030
20131—014
20141—012
20150—015
2016310209
20172—026
20183184026
20191—015
20200—07
20212—024
20221—016
20231—08
20240—09
20252—010
20261—0—

What is it indicated for?

ClearHemograsper has been designed to be used with endoscopes to cauterize and coagulate or to perform hemostasis using high-frequency current within the digestive tract.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K242857: ClearHemograsper.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K242857

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026